A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Trial Profile

A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2017

At a glance

  • Drugs LEO 130852A (Primary) ; Clobetasol
  • Indications Skin disorders
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 12 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 26 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 21 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top